JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Literature - Publication Review
Impact of taz deficiency on mitochondrial metabolism and pancreatic islet compensation in barth syndrome
A new study investigates how pancreatic islet function is preserved in Barth syndrome, a rare genetic disorder that disrupts mitochondrial metabolism. Leveraging Revvity's HTRF™ assay technology, the researchers uncovered unexpected compensatory mechanisms at the cellular and systemic level.
Key Findings:
- Preserved insulin secretion despite Taz-related mitochondrial dysfunction
- Increased glucagon secretion as an adaptive α-cell response
- FGF-21 signaling rescued β-cell function in vitro
Read the full publication review to learn how HTRF supported these insights.
To view the full content please answer a few questions
Download Resource
Impact of taz deficiency on mitochondrial metabolism and pancreatic islet compensation in barth syndrome
